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Abstract
Background: In the nervous system, as in other organs, Cu/Zn superoxide dismutase (Cu/Zn
SOD) is a key antioxidant enzyme involved in superoxide detoxification in normal cellular
metabolism and after cell injury. Although it has been suggested that immature brain has a different
susceptibility to oxidative damage than adult brain, the distribution and cell-specific expression of
this enzyme in immature brain and after postnatal brain damage has not been documented.
Methods:  In this study, we used immunohistochemistry and western blot to analyze the
expression of Cu/Zn SOD in intact immature rat brain and in immature rat brain after an NMDA-
induced excitotoxic cortical injury performed at postnatal day 9. Double immunofluorescence
labelling was used to identify Cu/Zn SOD-expressing cell populations.
Results: In intact immature brain, Cu/Zn SOD enzyme was widely expressed at high levels in
neurons mainly located in cortical layers II, III and V, in the sub-plate, in the pyriform cortex, in the
hippocampus, and in the hypothalamus. Glial fibrillary acidic protein-positive cells only showed Cu/
Zn SOD expression in the glia limitans and in scattered cells of the ventricle walls. No expression
was detected in interfascicular oligodendroglia, microglia or endothelial cells. Following excitotoxic
damage, neuronal Cu/Zn SOD was rapidly downregulated (over 2–4 hours) at the injection site
before neurodegeneration signals and TUNEL staining were observed. Later, from 1 day post-
lesion onward, an upregulation of Cu/Zn SOD was found due to increased expression in astroglia.
A further increase was observed at 3, 5 and 7 days that corresponded to extensive induction of
Cu/Zn SOD in highly reactive astrocytes and in the astroglial scar.
Conclusion: We show here that, in the intact immature brain, the expression of Cu/Zn SOD was
mainly found in neurons. When damage occurs, a strong and very rapid downregulation of this
enzyme precedes neuronal degeneration, and is followed by an upregulation of Cu/Zn SOD in
astroglial cells.
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Background
It has been shown that ~2–5% of the electron flow in iso-
lated brain mitochondria produces superoxide anion rad-
icals (O2
-.) and hydrogen peroxide (H2O2) [1]. Cellular
levels of O2
-.  are normally low due to the action of
cytosolic copper zinc superoxide dismutase (Cu/Zn SOD)
and mitochondrial manganese superoxide dismutase (Mn
SOD). These key enzymes catalyze the dismutation of O2
-
. to oxygen and H2O2 [2]. Increased production of super-
oxide and its derivatives can induce injury by diverse
mechanisms including initiation of lipid peroxidation,
inactivation of enzymes, damage to DNA, and protein
sulfhydryl oxidation. In particular, in the presence of
nitric oxide (NO.), O2
-. and NO. rapidly and spontane-
ously react to form the potent oxidant peroxynitrite
(ONOO-), which is capable of nitrating tyrosine [3,4]
contributing to the neuropathological process [5]. In this
sense, superoxide radicals have been identified as impor-
tant mediators of oxidative injury during ischemia-reper-
fusion and many other neurological injuries [6]. Cerebral
ischemia [7-9] and traumatic brain injury [10] cause a
rapid and sustained increase in the formation of O2
-.,
which is accelerated during mitochondrial dysfunction,
and may also result from increased activity of several
cytosolic enzymes as phospholipase A2 [11] or cycloxyge-
nase 2 (COX2) [7].
In the adult central nervous system (CNS), Cu/Zn SOD is
widely expressed in different neuronal populations: hip-
pocampal CA pyramidal neurons and granule neurons of
the dentate gyrus, cortical neurons, especially pyramidal
cells, neurons of the substantia nigra, and at very high lev-
els in motor neurons of the spinal cord [12-17]. In regards
to glial cells, it is generally assumed that microglial cells
and oligodendrocytes do not show expression of Cu/Zn
SOD [12,16-19], but the astroglial expression of this
enzyme is controversial. Some studies have found Cu/Zn
SOD expression primarily and most intensely in astro-
cytes [18,19], but a number of works have failed to detect
this expression in astrocytes [13-15,17], or have reported
expression only in some scattered astrocytes [12,16]. On
the other hand, expression of Cu/Zn SOD has been well
documented in reactive astrocytes several days after differ-
ent types of adult brain injury, like transient cerebral
ischemia [13], kainate treatment [14], quinolinic treat-
ment [18], or Alzheimer's and Down's Syndrome [16].
According with its antioxidant role, in most adult CNS
injury models the over-expression of Cu/Zn SOD is
thought to be neuroprotective [20-22]. In agreement, syn-
thetic O2
-. dismuting metalloporphyrins protect against
transient middle cerebral artery occlusion [23], and tar-
geted deletion of the Cu/Zn SOD or extracellular SOD
genes worsens outcome after focal ischemia [24,25].
However, contradictory results have been reported regard-
ing the toxicity of O2
-. after hypoxic/ischemic injury to the
immature brain. Whereas several antioxidant molecules
including SOD mimetics (as O2
-. dismuting metallopor-
phyrins) have been shown to be neuroprotective [26], a
slightly worsened neuropathological outcome is observed
in transgenic mice over-expressing Cu/Zn SOD [27]. Sev-
eral other differences in regards to oxidative stress and
antioxidant defences have been reported in the immature
versus the mature brain. For example, and in comparison
to the adult brain, in the immature damaged brain glu-
tathione peroxidase is not upregulated after trauma [28];
free iron accumulates more rapidly within 4 hours after
transient cerebral ischemia stimulating Fenton reactions
[29,30]; and metallothioneins, potent antioxidant
enzymes that bind transition metals as Zn, are less con-
centrated [31,32]. Finally, the postnatal brain is more sen-
sitive than the adult brain to the neurotoxic actions of N-
methyl-D-aspartate (NMDA) [33], which will lead to
increased O2
-.  generation [34,35]. Interestingly, it has
been reported that Cu/Zn SOD is rapidly downregulated
after several types of injury in the mature CNS
[13,14,36,37], but no data is available regarding this phe-
nomenon in immature brain, where overall findings sug-
gest a differential scenario for oxygen and nitrogen
reactive species in the evolution of a brain injury [38].
In this context, the aim of our study was to evaluate the
temporal and spatial dynamics, and the identity of Cu/Zn
SOD expressing-cells, in the intact immature rat brain,
and following an excitotoxic injury.
Methods
Excitotoxic lesions
Nine-day-old Long-Evans black-hooded rat pups of both
sexes were placed in a stereotaxic frame adapted for new-
borns (Kopf) under isofluorane anaesthesia. The skull was
opened using a surgical blade, and 0.15 µl of saline solu-
tion (0.9% NaCl, pH 7.4) containing 18,5 nmol of N-
methyl-D-aspartate (NMDA) (Sigma, M-3262, Germany)
were injected into the right sensorimotor cortex at the
level of the coronal suture (2 mm lateral from bregma and
at 0.5 mm of depth). Control animals received an injec-
tion of 0.15 µl of vehicle saline solution. After suture,
pups were placed in a thermal pad and maintained at nor-
mothermia for 2 hours before being returned to their
mothers. Experimental animal work was conducted
according to Spanish regulations, in agreement with Euro-
pean Union directives. This experimental procedure was
approved by the ethical commission of the Autonomous
University of Barcelona. All efforts were made to mini-
mize animal suffering in every step.
Immunocytochemical study
Intact immature brains from P9, P10, P12, and P16 rats of
both sexes where used for the analysis of Cu/Zn SODJournal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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expression under physiological conditions (2–4 animals
per time). Moreover, at 2, 4, and 10 hours, and 1, 3, 5 and
7 days after NMDA (3–4 animals per time) or saline injec-
tion (2 animals per time), rats were anaesthetized and per-
fused intracardially with 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4). Brains were post-fixed in the
same fixative for 2 hours and sunk in a 30% sucrose solu-
tion before being frozen with dry CO2. Coronal sections
(30-µm-thick) were obtained using a Leitz cryostat. Free-
floating parallel sections were treated with 10% foetal calf
serum in Tris-buffered saline (TBS: 0.05 M Trizma base
containing 150 mM of NaCl, pH 7.4) +1% triton X-100
for 1 hour, and incubated overnight at 4°C with sheep
polyclonal anti-Cu/Zn SOD (574597, Calbiochem,
Darmstad, Germany) (1:300) in the same solution. After-
wards, sections were rinsed and incubated for 1 hour at
room temperature with Cy3-conjugated anti-sheep sec-
ondary antibody (AP147C, Chemicon, California, USA)
(1:150). As negative controls, sections were incubated in
media lacking the primary antibody.
Double labelling with specific cell markers
Double labelling was carried out in order to identify Cu/
Zn SOD-expressing cells in sections previously immuno-
reacted for Cu/Zn SOD as reported above.
For neuronal identification, sections were further incu-
bated with a monoclonal anti-NeuN antibody (MAB377,
Chemicon, California, USA) (1:1000) and Cy2-conju-
gated anti-mouse secondary antibody (PA-42002, Amer-
sham Pharmacia Biotech, England) (1:1000).
For astroglial labelling, sections were incubated with a
polyclonal anti-GFAP antibody (Z-0334, Dakopatts, Den-
mark) (1:1800), and immunostaining was visualized with
Cy2-conjugated anti-rabbit secondary antibody (PA-
42004, Amersham Pharmacia Biotech, England)
(1:1000).
As a microglial marker, sections were processed for double
staining with tomato lectin histochemistry by incubating
with the biotinylated lectin from Lycopersicon esculen-
tum (tomato) (Sigma, L-9389, Germany) diluted to 6 µg/
ml, followed by Cy2-conjugated streptavidin (PA-42000,
Amersham Pharmacia Biotech, England) (1:1000).
Selected sections of all double labelling techniques were
incubated for 5 min with a 0.00125 µg/ml solution of 4,
6-diamino-2-phenylindole (DAPI) in TBS. Double-
stained sections were analyzed using a Nikon Eclipse
E600 epifluorescence microscope and a LEICA TCS SP2
AOBS confocal microscope.
TUNEL labelling
Terminal dUTP Nick End Labelling (TUNEL) staining for
detection of DNA fragmentation was performed on paral-
lel sections mounted on slides. Tissue sections were rinsed
in Tris buffer (10 mM, pH 8) and EDTA (5 mM) and then
incubated in the same buffer plus Proteinase K (20 µg/ml)
for 15 min. at room temperature. After several washes
with EDTA (5 mM), sections were incubated for 10 min.
in TdT buffer (Tris 30 mM, 140 mM Sodium Cacodilate, 1
mM Cobalt chloride, pH 7.7). Sections were then incu-
bated in TdT buffer plus 0.161 Units/ µl TdT enzyme (Ter-
minal Transferase, 3333566 Roche, Manheim, Germany)
and 0.0161 nmol/ µl of biotin-16-dUTP (1093070,
Roche, Manheim, Germany) for 30 min. at 37°C. The
reaction was stopped by washing the sections in citrate
buffer (300 mM sodium chloride, 30 mM sodium citrate,
5 mM EDTA). After several washes with TBS, sections were
incubated with avidin-peroxidase (P-0364, Dakopatts,
Denmark) (1:400) for another hour at room temperature.
Finally, the peroxidase reaction product was visualised in
100 ml of Tris buffer containing 50 mg of 3'-diaminoben-
zidine and 0.01% of hydrogen peroxide.
Western blotting and densitometry
Three or four NMDA-injected and two intact and saline-
injected animals for each survival time were decapitated,
and the complete injected cortex quickly extracted,
chopped and frozen in liquid nitrogen. Samples were
resuspended in Tris/HCl (50 mM, pH7.8), EDTA (1 mM),
DTT (1 mM), PMSF (100 µg/ml), pepstatin A (2 µg/ml),
leupeptin (2 µg/ml), trypsin inhibitor (10 µg/ml), benza-
midine (0.2 mM) and submitted to mechanical dissocia-
tion. Total protein concentration was measured by the
bicinchoninic acid method and equal quantities of pro-
tein were run on a 15% SDS-polyacrilamide gel electro-
phoresis (SDS-PAGE). Electrotransfered protein samples
to polyvinylidene fluoride (PVDF) membranes were incu-
bated overnight at 4°C with TBS+0.3% Tween 20 and 5%
non-fat milk, and for 2 hours at room temperature with
sheep polyclonal anti-Cu/Zn SOD (574597, Calbiochem,
Darmstad, Germany)(1:1000). Membranes were rinsed
and incubated in biotinylated anti-sheep antibody
(1:1000) (RPN-1025, Amersham Pharmacia Biotech, Eng-
land), avidin-peroxidase (1:2000) (P0364, Dakopatts,
Denmark) and finally in the chemiluminiscent substrate
SuperSignal West Pico (PIERCE) combined with exposure
on Hyperfilm ECL (Amersham).
Semi-quantitative estimation of western blot protein sig-
nals were performed by measuring band integral intensity
with analySIS® software after high resolution scanning.
Statistical analysis
All results are expressed as mean ± standard error mean
(SEM). ANOVA followed by Fisher's PLSD post-hoc testJournal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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was used to determine significant differences (p<0.05)
after western blot densitometry.
Results
Cu/Zn superoxide dismutase expression in the immature 
rat brain
As there is no available description of Cu/Zn SOD cell-
specific expression in the immature brain, we began our
study with this general description. No changes in the dis-
tribution pattern and cellular identity of Cu/Zn-express-
ing cells were found between P9 to P16 and thus will be
described in general. The immature rat brain showed
widespread immunoreactivity for Cu/Zn SOD, mainly
located in neurons. The most intense staining was
observed in pyramidal neurons located in cortical layers
V, III and II (Fig. 1A, B), in the pyriform cortex, and in the
pyramidal neurons of the olfactory tubercle. Sub-plate
neurons, a transient cell population located beneath the
cortical plate [39] were also among the most intense cells
(Fig 4A). In addition, hippocampal CA pyramidal neu-
rons and some inter neurons (Fig. 1C), as well as dentate
gyrus granular and sub-granular neurons, medial septum
neurons, and hypothalamic neurons also displayed
intense staining. There was also more diffuse staining in
many other neuronal populations as for example in vari-
ous thalamic nuclei, substantia nigra (Fig. 1D), and stria-
tum. Most of the immunoreactivity was mainly observed
in neuronal soma although less intense staining was also
present in the nuclei, sparing the nucleolus.
No specific Cu/Zn SOD immunoreactivity was detected in
parenchymal grey matter GFAP-positive astrocytes (Fig
2A). However, co-expression of Cu/Zn SOD and GFAP
was observed in scattered tanycytes of the third ventricle
wall (Fig 2B), in corpus callosum, and in astrocytes forming
the glia limitans (Fig 2C). Most ciliated ependymal cells
expressed Cu/Zn SOD (Fig. 2B). Moreover, besides the
ependymal cells described above, co-localization confocal
studies with tomato lectin, which specifically detects
microglial cells as well as endothelium [40], did not show
overlap with Cu/Zn SOD staining (Fig 2D). No consist-
ently Cu/Zn SOD-labelled cells were observed in white
matter tracts, which indicated that oligodendrocytes at
this location do not seem to express this enzyme.
Finally, western blots showed a significant developmental
increase in the total amount of brain Cu/Zn SOD between
P9 and P16 (Fig. 3B), evidenced as a single band of 16
KDa corresponding to the expected molecular mass of the
enzyme monomer.
Control intracortical saline injection caused a local and
transient increase in Cu/Zn SOD immunoreactivity
mainly in cortical neurons (data not shown) 10 hours
later surrounding the injection site. A trend towards a
rapid and transient increase could also be observed by
western blots (Fig 3B).
Cu/Zn superoxide dismutase expression after excitotoxic 
injury to the immature brain
As shown before, intracortical NMDA administration is a
model of excitotoxic damage that triggers rapid neuronal
death and tissue injury, which expands rostro-caudally
and includes part of the cortex, corpus callosum, dorsal
striatum, septum and rostral hippocampus [33,41].
In contrast to saline injected animals, as observed both by
western blot tendencies (Fig. 3) and immunohistochem-
istry (Fig. 4, 5) at 2–4 hours after NMDA injection, the
lesioned neural parenchyma showed a drastic downregu-
lation of total Cu/Zn SOD immunoreactivity in neuronal
cells, which returned to basal levels 24 hours after the
lesion and increased significantly thereafter due to expres-
sion in astroglial cells. Interestingly, the early decrease in
neuronal Cu/Zn SOD immunoreactivity at 2–4 hours
(Fig. 4A–B) was accompanied by a slight condensation of
nuclear chromatin (Fig. 4C–D) and changes in NeuN neu-
ronal marker (Fig. 4F–G), in the absence of apparent signs
of neuronal degeneration or TUNEL staining (Fig. 4H). At
later time points, from 10 hours, degenerating neurons
still showed downregulated Cu/Zn SOD immunoreactiv-
ity, but displayed condensed nuclei, nuclear blebbing
(Fig. 4E) and also DNA fragmentation observed by
TUNEL staining (Fig. 4I). Downregulation of Cu/Zn SOD
and signs of neuronal degeneration were observed from
10 hours in primary cortical degenerating areas and from
1 day post-lesion in secondary degenerating regions such
as the cortical, striatal and hippocampal penumbra (Fig.
5A). However, the total Cu/Zn SOD enzyme level
increased from 1 day post-lesion, reaching a maximum
induction after 3–7 days (Fig 3B and 5B), due to astroglial
upregulation of the enzyme. Cu/Zn SOD was induced in
the soma and proximal projections of the most hypertro-
phied and most intensely GFAP-immunopositive astro-
glial cells of the whole degenerative area including the
white matter (Fig. 5C), but not in slightly activated astro-
cytes with lower GFAP immunoreactivity. This elevated
expression continued at 5 and 7 days post-lesion when
most astrocytes of the degenerative area were strongly
hypertrophic and formed the glial scar (Fig. 5D). Only
scattered reactive microglial cells expressed Cu/Zn SOD at
3 days after lesion, but most reactive microglial cells of the
lesioned parenchyma remained negative.
Discussion
In the last decade, progress has been made regarding the
complex evolution of damage in the developing brain
[38] and how it differs with adult brain injury. In this
sense, one of the divergences proposed is that immature
brain deals poorly with oxidative stress. In this study, weJournal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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Neuronal Cu/Zn SOD immunoreactivity in intact immature brain Figure 1
Neuronal Cu/Zn SOD immunoreactivity in intact immature brain. Widespread immunoreactivity for Cu/Zn SOD 
was observed mainly in neurons, both in the cytoplasm and nucleus, sparing the nucleolus. In the cortex, the highest expression 
was observed in cortical pyramidal neurons of layers V and III and II (A, B: Parietal cortex). In addition, the hippocampal 
pyramidal layer (CA1; C), and of substantia nigra (D) also displayed immunoreactivity. Scale bars: 50 µm in A and B; 20 µm in 
C and D.Journal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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Glial distribution of Cu/Zn SOD immunoreactivity in intact immature brain Figure 2
Glial distribution of Cu/Zn SOD immunoreactivity in intact immature brain. Cu/Zn SOD was not observed in the 
GFAP-expressing astrocyte population of the brain parenchyma (A: cortex, confocal image). However, GFAP-expressing astro-
cytes showed co-localization with Cu/Zn SOD in the glia limitans (C, confocal image) and in the ventricle walls (B: third ventri-
cle; arrow: tanycyte). Microglial cells and endothelium (arrow), identified with tomato lectin histochemistry, were negative for 
Cu/Zn SOD (D: cortex; confocal image). Scale bars in A: 40 µm; in B, C and D: 20 µm.Journal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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Total Cu/Zn SOD expression in control, and saline or NMDA injected postnatal cortex Figure 3
Total Cu/Zn SOD expression in control, and saline or NMDA injected postnatal cortex. Western blot (A) and 
semi-quantification of total levels of Cu/Zn SOD protein from intact, saline-injected, or NMDA-injected brain cortical extracts 
are represented as percentage of Cu/Zn SOD level in P9 (B). A single band of the expected molecular weight of 16 KDa of the 
Cu/Zn SOD monomer was observed in all samples (A). The intracortical injection of saline solution induced a trend towards 
the transient upregulation of Cu/Zn SOD which showed a peak at 10 hours post-injection (B: solid circles). In contrast, after 
NMDA injection, total cortical Cu/Zn SOD expression showed a trend towards rapidly diminishing (A, B: triangles). This trend 
of Cu/Zn SOD reduction at 4 hours after NMDA injection in total cortical extracts is comparable to the % of lesioned cortex 
which was around 20% (not shown). However, at later time points, Cu/Zn SOD was significantly upregulated peaking at 7 days 
(168 hours) post-lesion. In intact control brain (B: opened circles), total enzyme level significantly increased from postnatal day 
9 to postnatal day 16. (# p < 0.05 in relation to P9 control animals and * p < 0.05 in relation to NMDA 4 hours).Journal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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have shown that the expression of the key antioxidant
enzyme Cu/Zn SOD is mainly found in neuronal cells.
When damage occurs, a strong neuronal downregulation
of this enzyme precedes both neuronal cell death and the
subsequent Cu/Zn SOD upregulation in astroglial cells.
Cu/Zn SOD in the intact immature brain
It is well known that total brain levels of antioxidant
enzymes vary throughout life [32,41,42]. Accordingly,
brain glutathione peroxidase and Mn SOD were reported
to increase during the first month of postnatal rat life, and
to continue increasing slightly during adulthood and
aging [28,43-46]. Catalase has been reported to peak
around the first week of life and then decline to reach a
plateau by the first month [43,44]. Regarding Cu/Zn SOD,
it is known that its levels increase rapidly after birth, peak-
ing around the second postnatal week, in agreement with
our western blot studies. Later on, Cu/Zn SOD decreases
Cell-specific Cu/Zn SOD expression in the early excitotoxicaly lesioned immature brain Figure 4
Cell-specific Cu/Zn SOD expression in the early excitotoxicaly lesioned immature brain. In the injection site, Cu/
Zn SOD immunoreactivity decreased from 2–4 hours after the NMDA injection, and continued to be downregulated until 24 
hours after injection (A-B,SPN: sub-plate neurons, V and II-III: cortical layers). Neurons from the injected cortex after 4 
hours showed slightly condensed chromatin (compare C and D: arrows), and a shift of NeuN staining from the soma and 
nucleus towards the nucleus (compare F and G: arrows) in the absence of TUNEL staining (H). From 10 hours after lesion 
onward, neuronal nuclei showed clear apoptotic signals like condensation and blebbing (E: arrows) and TUNEL staining (I). 
Scale bars in A-B: 200 µm; in C-G 5 µm; and in I-H: 40 µm.Journal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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slightly to reach adult levels, but increases slightly again in
aging [42,44,45]. Thus, it seems clear that immature rat
brain has a different balance of antioxidant enzymes,
which reach the adult overall pattern only after the first
month of life.
We have shown that in the postnatal brain the majority of
Cu/Zn SOD immunoreactivity is observed in neuronal
somas with less intense staining present in the nuclei,
sparing the nucleoli, as has been reported earlier for adult
animals [12-17,47]. Accordingly, even though changes in
Cu/Zn SOD levels occur in postnatal development, the
cell type distribution of this enzyme does not change.
Neurons are the brain cells with the highest oxygen con-
sumption, constantly submitted to oxidative stress as it is
suggested by O2
-. mediated oxidation of hydroethidine
Cell-specific Cu/Zn SOD expression in the late excitotoxicaly lesioned immature brain Figure 5
Cell-specific Cu/Zn SOD expression in the late excitotoxicaly lesioned immature brain. One day after the lesion 
(A), neuronal bodies were condensed in the lesioned zone (*) when compared to the penumbra zone (Pen). Moreover, the 
lesion core (*) showed very low or no expression of Cu/Zn SOD. In contrast, 3 days after injection, cortical expression of Cu/
Zn SOD increased in the whole lesion (B, *). Neurons in the penumbra (B, Pen) and reactive hypertrophic astrocytes (C) 
within the degenerative core (*) expressed Cu/Zn SOD after 3 days. These GFAP-positive hypertrophic astrocytes were the 
main cell type expressing Cu/Zn SOD in the lesion core (D). This pattern of expression was maintained until 7 days post-lesion 
(the last time analyzed), when the glial scar was evident. Scale bars in A-D: 20 µm.Journal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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[9], or by the presence of nitrotyrosine [48,49]. Accord-
ingly, it is not surprising that high levels of Cu/Zn SOD
are observed in a wide number of neuronal populations,
specifically in the large neurons with high energetic
requirements, like pyramidal neurons, or catecholaminer-
gic neurons which are submitted to elevated oxidative
stress due to catecholamine metabolism [50]. Very
recently, a site for the pro-inflammatory transcription fac-
tor NFκ B has been reported at the human Cu/Zn SOD
promoter, which can induce its expression [51]. Accord-
ingly, in the CNS, neurons are the main cells that display
constitutively activated NFκ B [52,53], and its activity is
required for their survival [54]. In addition, the other
important cellular superoxide dismutase, the Mn SOD, is
also enriched in subsets of neurons [55], although differ-
ent from those enriched in Cu/Zn SOD.
No immunoreactivity for Cu/Zn SOD was observed in the
GFAP-expressing astrocyte population of the neural
parenchyma in the immature brain, as has been previ-
ously reported for adult brain [13-15,17,47], and despite
the fact that immature astrocytes differ from adult astro-
cytes. This lack of Cu/Zn SOD expression contrasts with
the higher tolerance of astrocytes to oxidative stress
[48,56]. Accordingly, and in comparison with neuronal
cells, astrocytes in culture have been shown to have higher
levels of glutathione and the lipophilic antioxidant vita-
min E [57], and they are capable of synthesizing their own
glutathione from cysteine [58], mechanisms that proba-
bly confer upon astrocytes an elevated antioxidant status
and increased resistance towards oxidative stress, despite
the absence of detectable levels of Cu/Zn SOD. Notewor-
thy, Cu/Zn SOD immunoreactivity is only found in glia
limitans astrocytes and in GFAP-positive tanycytes, which
could be attributed to the contact of these astrocytes with
non-CNS molecules, which are also known to induce the
expression of several other activation markers observed
previously in these regions, like GFAP overexpression,
vimentin or metallothioneins [41]. Regarding microglial
cells, neither resting ramified microglia nor amoeboid
microglial cells found in the immature brain showed Cu/
Zn SOD immunoreactivity, as has been shown for adult
resting microglial cells [12,17,47]. In addition, we were
unable to find consistent immunoreactivity for Cu/Zn
SOD in white matter oligodendrocytes of immature brain,
as has been described in the adult [12,17,47]. The lack of
this enzyme could help explain the well known high sen-
sitivity of oligodendrocytes to excitotoxicity and oxidative
stress [59], especially in the immature brain where white
matter injury is thought to be the underlying mechanism
of brain damage [38].
Cu/Zn SOD in the injured immature brain
After an excitotoxic injury to the postnatal brain, we have
observed a dramatic and rapid neuronal downregulation
of Cu/Zn SOD in the NMDA injection site, which is early
evident 2–4 hours after injection in neurons that only
show slight and very early signs of degeneration and are
negative for TUNEL staining. In fact we have previously
shown that these neurons display, 10 hours after NMDA
injection, NFκ B activation and COX2 upregulation, sug-
gesting that they are still active and functional [53,60].
The Cu/Zn SOD downregulation also coincides with neu-
ronal nitration [48] suggesting endogenous O2
-./peroxyni-
trite formation at these very early time points in
compromised neurons. Although to our knowledge this is
the first study describing the expression of Cu/Zn SOD
after immature brain damage, studies on adult brain
injury have also shown, as early as 4 hours after transient
cerebral ischemia, Cu/Zn SOD immunoreactivity down-
regulation in striatum and cortex [37] and in neurons of
the hippocampal CA region [13]. Moreover, 24 hours
after injection of kainate to adult rat hippocampus, Cu/Zn
SOD immunoreactivity is also downregulated in neurons
of CA, despite an absence of apparent neuronal degenera-
tion at that time-point [14]. Accordingly, it is known that
superoxide scavengers protect from injury at these early
time points [23,26,61]. Although the mechanism
whereby this rapid downregulation occurs is not clear, it
appears that it could be mediated by oxidative stress, as
PC12 cells treated with H2O2  rapidly (after 4 hours)
downregulate Cu/Zn SOD [51]. Interestingly, hypother-
mia, the most powerful neuroprotective strategy known,
not only inhibits the rapid downregulation of Cu/Zn SOD
after a traumatic brain injury but also induces its over-
expression [36]. Most surprisingly, this effect is specific for
Cu/Zn SOD, and in fact hypothermia induces a less signif-
icant upregulation of other antioxidant enzymes such as
catalase and glutathione peroxidase in comparison with
non-hypothermic brain.
Contradictory results have been reported regarding the
toxicity of O2
-. after hypoxic/ischemic injury to the imma-
ture brain. Whereas slightly worsened neuropathological
outcome was observed in transgenic mice overexpressing
Cu/Zn SOD and submitted to severe hypoxia/ischemia
[27], several antioxidant molecules including SOD
mimetics as O2
-.  dismuting metalloporphyrins were
shown to be neuroprotective [26]. One hypothesis is that
Cu/Zn SOD transgenic mice produce excess H2O2 that in
the immature brain is not cleared by the upregulation of
the glutathione peroxidase as has been reported for adult
animals [28,62]. However, an additional explanation
would be that as the postnatal brain express increased
amounts of the NMDA receptor [63], whose activation
leads to increased O2
-.  generation [34,35], an initial
enhanced oxidative stress would occur. Taken together,
this data suggest that in the immature brain subjected to
ischemia/excitotoxicity, neurons at the lesion zone are
very early submitted to an elevated oxidative stress, andJournal of Neuroinflammation 2005, 2:12 http://www.jneuroinflammation.com/content/2/1/12
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therefore Cu/Zn SOD downregulation contributes to the
further amplification of cell damage and neuronal cell
death.
Although Cu/Zn SOD expression remains very low in
compromised neurons, a return to normal expression lev-
els is seen by 24 hours after lesion, and an increase in total
enzyme level is observed later on. This secondary Cu/Zn
SOD induction is due to upregulation in reactive hyper-
trophic astrocytes within the lesion site. We have shown
in previous studies that these reactive astrocytes display
activated NFκ B from 10 hours after the excitotoxic lesion
[53], which could contribute to the induction of the Cu/
Zn SOD observed here. We have also shown that the
hypertrophic Cu/Zn SOD-overexpressing astrocytes are
heavily nitrated, and also display metallothionein I-II
expression, suggesting an elevated rate of oxidative stress
in this particular group of cells [48]. Our findings in
immature brain are in accordance with studies of adult
brain damage that have shown induction of Cu/Zn SOD
and Mn SOD in astrocytes several days after focal ischemia
[37] excitotoxicity [14,18], or in Alzheimer's disease and
Down's Syndrome [16]. In addition to the upregulated
enzymatic antioxidant defences, astrocytes have been
shown to produce their own glutathione and also provide
neurons with cysteine, a rate-limiting precursor in neuro-
nal glutathione synthesis [58]. Thus, astrocytes seem to be
the main cell type increasing the total antioxidant capabil-
ities in the nervous tissue after a lesion, which can in addi-
tion explain their elevated resistance to cell death after an
injury. In this sense, previous studies showed that Cu/Zn
SOD-overexpressing astrocytes have increased resistance
to oxidative damage [64] and attenuated oxidative inhibi-
tion of glutamate uptake [65], allowing for a maintenance
of their physiological functions after a lesion.
Regarding microglial cells, it is somehow surprising that
only a reduced number of reactive ameboid microglial
cells express Cu/Zn SOD, and that this occurs very tran-
siently, as in some circumstances activated microglia
produce large amounts of oxygen radicals after a lesion
including O2
-. [66].
We believe that the results presented here highlight the
importance of in vivo cell-localization studies for antioxi-
dants, as some of the reactive species like O2
-. do not dif-
fuse across cell membranes and thus will most probably
react within the cell where it is formed.
Conclusion
In conclusion, we show that in the intact immature rat
brain during the plasticity window, Cu/Zn SOD is mainly
expressed in neurons, though it is also expressed at the
central nervous system boundaries like the glia limitans or
the ependymal cells. Moreover, we show that brain Cu/Zn
SOD expression levels vary after an excitotoxic injury: it is
rapidly downregulated in neurons, rendering the affected
neurons even more susceptible to oxidative damage, and
later on it is upregulated in highly hypertrophic astrocytes.
Therefore, as no changes in cell specificity are found in the
immature versus the adult brain, further studies would be
needed to elucidate the mechanisms underlying the differ-
ent susceptibility to oxidative damage in these two lesion
paradigms.
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